Exclusive special offer and discount title banner vector image

NORTH AMERICA AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

SCOPE OF THE REPORT

North America Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilized Amniotic Membrane) Market by Application (Surgical Wounds, Ophthalmology, Other Applications) Market by End-user (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers & Laboratories) by Geography


MARKET OVERVIEW

The North America amniotic membrane market is expected to record a CAGR of 7.07% during the forecast period, 2023-2032, and is estimated to reach a revenue of $1130.43 million by 2032

The amniotic membrane market growth in North America is attributed to the presence of prominent market players and well-established healthcare facilities. Also, the growing focus on alternative technologies and the adoption of advanced technologies contribute to market growth. However, the North America amniotic membrane market growth is hampered by high expenses.

To Know More About This Report, Request a Free Sample Copy

The North America amniotic membrane market growth evaluation includes the analysis of the United States and Canada. The United States amniotic membrane market growth is attributed to the thriving biotechnology sector with regard to regenerative medicine development. Also, the US market benefits from the presence of key market players offering different products made from placental cells. In addition, numerous companies are significantly investing in the development of amniotic products. Consequently, the development of amniotic products has facilitated market demands in the regenerative medicine and advanced wound care segments. 

For instance, BioTissue Inc developed PROKERA Slim corneal bandage in August 2020, approved for use in ocular surface disease and disorders. Further, in January 2021, Organogenesis Holdings Inc announced the grant of ReNu®, a cryopreserved amniotic suspension allograft, by the US Food and Drug Administration (FDA) for managing symptoms associated with knee osteoarthritis (OA). Besides, the American Association of Tissue Banks supplements the development of amniotic membranes and enables accreditation for the distribution of the amniotic membrane or tissues. 

Furthermore, the United States amniotic membrane market prospects are defined by the vast use of amniotic membranes for eye surface disorders. Accordingly, the increasing number of ophthalmic surgeries due to the rising geriatric population is lucrative to the analyzed market’s growth. Moreover, according to the US National Library of Medicine, the application of amniotic membranes has a wide indication spectrum in treating ocular surface disorders. Amniotic membrane transplantation has been routinely incorporated as part of ocular surface reconstruction in varied ocular pathologies. 

The North America amniotic membrane market segmentation includes end-user, application, and product. The end-user segment includes specialized clinics, hospitals, ambulatory surgical centers, and research centers & laboratories.

Specialized clinics focus on the care of outpatients and a specific medical area. The providers in a specialized clinic are specifically trained in fields like dermatology, cardiology, gastroenterology, orthopedics, ophthalmology, sports medicine, neurology, etc. They are also stand-alone practices, and at the same time, often associated with a hospital group or healthcare system. They use a high-volume/cross-subsidization model to meet the huge patient demands and medical needs of the underprivileged, particularly in the areas of dentistry, kidney care, reproductive health, and eye care. The growing number of healthcare players and the increasing number of health conditions propel the growth of the segment. 

Some of the prominent firms in the North America amniotic membrane market include MiMedx Group Inc, Labtician Ophthalmics Inc, Organogenesis Inc, Smith & Nephew Plc, etc.

MiMedx is an advanced wound care and biologics company that develops and distributes placental tissue allografts. It provides products in the dental, ophthalmic, sports medicine, spine, orthopedic, surgical, burns, and wound care sectors. Its products are used in surgical applications, including plastic surgery, extremity repair, multiple orthopedic repairs and reconstructions, and vascular surgery. The company has two main distribution channels, distributors and direct-to-customers, with headquarters in Marietta, Georgia.

One of its biomaterial platform technologies, AMNIOFIX, is a dehydrated human amnion/chorion membrane allograft. It is available in wrap, fenestrated, and sheet configurations in various sizes to minimize wastage. Besides, it is derived from donated C-sections of live births in the US.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2021
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product, Application, End-User
Countries AnalyzedThe United States and Canada
Companies Analyzed

Amnio Technology LLC, Applied Biologics, BioTissue Inc, Celularity, Corza Ophthalmology, Human Regenerative Technologies LLC, Integra LifeSciences, Labtician Ophthalmics Inc, MiMedx Group Inc, Organogenesis Inc, Smith & Nephew Plc, Skye Biologics LLC, Stryker Corporation, Surgenex LLC, SurgiLogix LLC

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
    5. MAJOR MARKET FINDINGS
      1. AMNIOTIC MEMBRANE IS MAJORLY USED FOR OCULAR APPLICATIONS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. INCREASING RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
      2. GROWING AWARENESS REGARDING NUMEROUS APPLICATIONS OF AMNIOTIC MEMBRANE
      3. RISING DEMAND FOR WOUND CARE TREATMENT 
    2. KEY RESTRAINTS
      1. DIFFICULTIES ASSOCIATED WITH AMNIOTIC MEMBRANE USE
      2. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY PRODUCT
    1. CRYOPRESERVED AMNIOTIC MEMBRANE
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. LYOPHILIZED AMNIOTIC MEMBRANE
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY APPLICATION
    1. SURGICAL WOUNDS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. OPHTHALMOLOGY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTHER APPLICATIONS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY END-USER
    1. HOSPITALS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. AMBULATORY SURGICAL CENTERS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. SPECIALIZED CLINICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    4. RESEARCH CENTERS & LABORATORIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA AMNIOTIC MEMBRANE MARKET DRIVERS
      3. NORTH AMERICA AMNIOTIC MEMBRANE MARKET CHALLENGES
      4. NORTH AMERICA AMNIOTIC MEMBRANE MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA AMNIOTIC MEMBRANE MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA AMNIOTIC MEMBRANE MARKET SIZE & OPPORTUNITIES
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
    2. COMPANY PROFILES
      1. AMNIO TECHNOLOGY LLC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      2. APPLIED BIOLOGICS
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
      3. BIOTISSUE INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      4. CELULARITY
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      5. CORZA OPHTHALMOLOGY
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      6. HUMAN REGENERATIVE TECHNOLOGIES LLC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      7. INTEGRA LIFESCIENCES
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      8. LABTICIAN OPHTHALMICS INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      9. MIMEDX GROUP INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      10. ORGANOGENESIS INC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      11. SMITH & NEPHEW PLC
        1. COMPANY OVERVIEW
        2. FINANCIAL ANALYSIS
        3. PRODUCT LIST
        4. STRENGTHS & CHALLENGES
      12. SKYE BIOLOGICS LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      13. STRYKER CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      14. SURGENEX LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      15. SURGILOGIX LLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST

LIST OF TABLES

TABLE 1: NORTH AMERICA MARKET SNAPSHOT – AMNIOTIC MEMBRANE

TABLE 2: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 3: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 5: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 7: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: NORTH AMERICA REGULATORY FRAMEWORK

TABLE 11: KEY PLAYERS OPERATING IN NORTH AMERICA AMNIOTIC MEMBRANE MARKET

TABLE 12: LIST OF ACQUISITIONS

TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: MARKET MATURITY ANALYSIS

FIGURE 5: MARKET CONCENTRATION ANALYSIS

FIGURE 6: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022

FIGURE 7: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY CRYOPRESERVED AMNIOTIC MEMBRANE, 2023-2032 (IN $ MILLION)

FIGURE 8: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY LYOPHILIZED AMNIOTIC MEMBRANE, 2023-2032 (IN $ MILLION)

FIGURE 9: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 10: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2023-2032 (IN $ MILLION)

FIGURE 11: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2023-2032 (IN $ MILLION)

FIGURE 12: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 13: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022

FIGURE 14: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)

FIGURE 15: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY AMBULATORY SURGICAL CENTRES, 2023-2032 (IN $ MILLION)

FIGURE 16: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY SPECIALIZED CLINICS, 2023-2032 (IN $ MILLION)

FIGURE 17: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, BY RESEARCH CENTERS & LABORATORIES, 2023-2032 (IN $ MILLION)

FIGURE 18: NORTH AMERICA AMNIOTIC MEMBRANE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 19: UNITED STATES AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 20: CANADA AMNIOTIC MEMBRANE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 21: CELULARITY- COMPANY NET PROFIT, IN 2018-2021 (IN $ MILLION)

FIGURE 22: CELULARITY- COMPANY REVENUE, IN 2018-2021 (IN $ MILLION)

FIGURE 23: INTEGRA LIFESCIENCES – COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 24: INTEGRA LIFESCIENCES- COMPANY REVENUE, IN 2017-2021 (IN $ BILLION)

FIGURE 25: MIMEDX GROUP INC – COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 26: MIMEDX GROUP INC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)

FIGURE 27: ORGANOGENESIS INC – COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 28: ORGANOGENESIS INC – COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)

FIGURE 29: SMITH & NEPHEW PLC- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)

FIGURE 30: SMITH & NEPHEW PLC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)

FAQ’s